To hear about similar clinical trials, please enter your email below
Trial Title:
Effect of Ultrasound Cavitation Versus Electrolipolysis on Obese Infertile Women With Polycystic Ovarian Syndrome
NCT ID:
NCT06490419
Condition:
Polycystic Ovary Syndrome
Conditions: Official terms:
Polycystic Ovary Syndrome
Syndrome
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
Single (Outcomes Assessor)
Intervention:
Intervention type:
Device
Intervention name:
Electrolipolysis
Description:
Hypocaloric diet:
All patients were prescribed balanced hypocaloric diet (1200 kcal/day) by the nutrition
specialist, with physiological nutrient content: carbohydrates-50%, proteins-20%,
fats-30% and fiber daily consumption of 30 - 40 g in dry form (grain and vegetables).
Calorie distribution: breakfast-40%, lunch-40%, dinner-20%. Behavioral therapy to correct
eating disorders: diary of food and lifestyle, motivational phone calls every week
Electrolipolysis:
the participants will receive electrolipolysis applied to abdomen, thigh and gluteal
regions, 3 sessions/week, for 3 months, 60 minutes/session; 30 minutes on the abdomen and
thigh and 30 minutes on gluteal region. the device will be set to cause a contraction for
4 seconds followed by a relaxation for 4 seconds with a pulse width of 400 microseconds
and a frequency of 20 pulses per minute.
Arm group label:
electrolipolysis group
Intervention type:
Device
Intervention name:
ultrasound cavitation
Description:
Hypocaloric diet:
All patients were prescribed balanced hypocaloric diet (1200 kcal/day) by the nutrition
specialist, as in the electrolipolysis group.
ultrasound cavitation (UC): The participants will be treated by UC on the abdomen for 30
minutes, two sessions per week for 3 months. From standing position, the abdominal area
of each patient will be divided transversally into 3 parts; part I: from the xiphoid
process to 3 cm above the umbilicus, part II: from 3cm above the umbilicus to 2 cm below
the umbilicus and part III: from 2 cm below the umbilicus to the pubic bone. Vertically,
each part will be divided into right and left segments in relation to the linea alba,
forming a total of 6 abdominal segments.
The program of cavitation; frequency (40 kHz) will be chosen, the time will be adjusted
at 30 minutes. The cavitational head will be, then, moved very slowly on each abdominal
segment in a small circular movement for 5 minutes.
Arm group label:
ultrasound cavitation group
Summary:
This study aims to determine the difference between the effect of ultrasound cavitation
and electrolipolysis on obese infertile women with polycystic ovarian syndrome.
Detailed description:
Polycystic ovarian syndrome (PCOS) is the most prevalent endocrinopathy among women
during reproductive age . PCOS affects 5-10% of women in reproductive age. It has an
effect on quality of life , fertility and pregnancy.
Obesity plays a significant role in reproductive disorders, particularly in women. It is
associated with anovulation, menstrual disorders, infertility, difficulties in assisted
reproduction, miscarriage, and adverse pregnancy outcomes.
The treatment of obesity and infertility causes some harm to women, due to the danger of
some operations and medications other than the high cost of these operations, so it is
necessary to use a therapeutic alternative that is non invasive, with lower risk and
lower cost.
Both ultrasound cavitation (UC) and electrolipolysis are non invasive modalities with
many positive effects on obesity and PCOS outcomes. The effect of both the UC and
electrolipolysis has been separately investigated in previous studies. Though, no studies
were found to compare the effect of both modalities in the management of infertile women
with PCOS. Therefore, this study will be conducted to explore the effect of UC versus
electrolipolysis on infertile women with PCOS.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Infertile married PCOS women, diagnosed by Rotterdam criteria .
- Their ages will be ranged between 25-35 year old.
- Their BMI will be ranged from 30-40 kg/ m2.
- Their waist/hip ratio equal to or more than 0.85
Exclusion Criteria:
- Thyroid dysfunction (hypothyroidism).
- Chronic and/or systemic illnesses (e.g. diabetes mellitus, liver, renal respiratory
failure and cardiovascular disorders).
- Malignant tumors.
- Tubal adhesions as well as uterine abnormalities.
- Skin diseases in the abdominal and gluteal regions.
- Conditions that may prevent the use of electrical stimulation.
Gender:
Female
Gender based:
Yes
Minimum age:
25 Years
Maximum age:
35 Years
Healthy volunteers:
Accepts Healthy Volunteers
Start date:
July 10, 2024
Completion date:
December 10, 2024
Lead sponsor:
Agency:
Cairo University
Agency class:
Other
Source:
Cairo University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06490419